This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Oncology  • Breast Cancer  • Women's Health  • Women's Health, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Tracy Hampton, PhD

JAMA. 2006;295:2128-2129.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

New research presented at the annual conference of the American Association for Cancer Research suggests that vitamin D and cyclooxygenase-2 (COX-2) inhibitors may help reduce the risk of breast cancer. The findings may help women, particularly those at elevated risk, take steps to prevent the development of this disease, although experts caution that any anticancer benefits of the COX-2 inhibitors will have to be balanced against the drugs' cardiovascular risks.

THE SUNSHINE VITAMIN

Individuals who live in warm and sunny climates enjoy not only pleasant weather but also a decreased risk of developing some cancers. Epidemiological studies have demonstrated that there is higher mortality from colon, breast, and several other types of cancer in the northeastern United States than in the southwest and that the geographic distribution of these malignancies is related inversely to solar radiation (Grant WB. Cancer. 2002;94:1867-1875).

New studies suggest that vitamin D and cyclooxygenase-2 (COX-2) . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?